You are here

Effective clinical development planning for Phase I

Tuesday, 8 October, 2019 - 08:00 to 09:30

Welcome to a breakfast seminar that we host together with Recipharm and CTC focusing on the first step from drug discovery to clinical projects which has the potential to add significant value for small companies and can for many be the make it or break it for the drug candidate and the company. 

The speakers will guide you in how to avoid pitfalls and what to consider when building an effective clinical program with that extra value. Focus will be on the development and manufacturing of clinical trial material, the planning, performing and reporting of your clinical trial as well as important bioanalytical considerations.

Anders Millerhovf, CEO, CTC Clinical Trial Consultants AB
David Pekar, GLP Test Site Manager, Recipharm AB
Torkel Gren, Science & Technology Officer,  Recipharm AB

When: October 8 at 8:30 – 9:30, breakfast is served between 8:00 and 8:30
Where: Sveavägen 166, Wenner-Gren Center, 24th floor

The registration is now closed, please contact if you would like to participate.

About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation that manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies.

About CTC Clinical Trial Consultants
CTC Clinical Trial Consultants is a Swedish full-service CRO with clinical conduct in focus. The mission is to facilitate clinical and translational research by providing customers with cost-effective advice and implementation of early clinical trials (Phase 0/I /IIa).

Please note that this seminar will be held in Swedish.